31st January 2025
- 0 comments
Atelerix, a Newcastle University spinout that is transforming the way that biosamples essential for drug discovery and pharmaceutical research are stored and transported, has raised £750k, with participation from ACF Investors and biotech specialist investors o2h Ventures, bringing the year's total funding to £1.25m. The investment will be used to drive the company's branding and sales efforts and drive widespread adoption of its technology, positioning Atelerix's range of hydrogels as the preferred shipping method for biosamples.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.